A groundbreaking initiative is offering a glimmer of hope to rare cancer patients, promising a better chance at survival through innovative clinical trials and cutting-edge treatments.
The Fight Against Rare Cancers: A New Approach
The UK government is taking a bold step towards improving the lives of rare cancer patients. By prioritizing neglected rare cancers and enhancing access to clinical trials, they aim to revolutionize the treatment landscape.
Here's the crux: rare cancer patients will now have faster access to life-changing clinical trials through the NHS App. This digital revolution ensures that patients can actively participate in research, benefiting from the latest medical advancements.
Unveiling the National Cancer Plan
As part of the government's National Cancer Plan and the Rare Cancers Bill, patients will have the opportunity to engage in clinical trials via the NHS App. This approach empowers patients to take control of their health, offering innovative solutions to combat their diseases.
Initially, patients can search for trials on the clinical research database and request to be contacted. Over time, the process will become even more streamlined, allowing patients to automatically receive details of relevant trials, ensuring they don't miss out on potentially life-saving opportunities.
Expanding Digital Healthcare
The expansion of the 'doctor in your pocket' NHS App is a significant step towards creating a digitally empowered NHS. From booking appointments to managing ongoing care and receiving notifications about the latest research trials and treatments, the app aims to provide a seamless and efficient healthcare experience.
Ensuring No One is Left Behind
The government's commitment to rare cancer patients doesn't stop there. Over the next three years, the Rare Cancers Bill will incentivize research and investment, providing consistent access to research and accelerating the journey from discovery to treatment. This initiative ensures that more cancer experts are hired to drive these much-needed changes.
Boosting Brain Cancer Research
In addition to the above, a total of £32.3 million has been allocated to boost brain cancer research since July 2024. This funding will support the development and enhancement of trials, focusing on precision medicine and tailored treatments. It will also help cultivate the next generation of leaders in brain cancer research.
Recruiting Top Cancer Experts
To further enhance the clinical trial process, top cancer experts will be recruited. These experts will play a crucial role in speeding up trial referrals, whether through the app or face-to-face appointments. The appointment of a new national lead for rare cancer and the creation of a Speciality Lead for Rare Cancers by the National Institute for Health and Care Research will ensure a more coordinated approach to clinical trials for rare cancer patients.
A Message from the Secretary of State for Health and Social Care
Wes Streeting, the Secretary of State for Health and Social Care, understands the pain and frustration rare cancer patients and their families face. He emphasizes that the modernization of the NHS aims not only to provide faster access to breakthrough treatments but also to ensure that more experts are in place to boost survival rates for rare cancers across the country.
The National Cancer Plan: A Step-Change
The National Cancer Plan marks a significant turning point for brain cancer and rare cancer patients. It provides researchers with the tools they need and gives patients the hope they deserve. With this plan, the government aims to lead Europe in survival rates for 14 less common and deadly cancers, including brain cancer, by 2035, building an NHS that is fit for the future.
Strengthening Partnerships for a Brighter Future
The government is strengthening its partnership with Cancer Research UK, co-funding the CRUK Brain Tumour Centres of Excellence with £3 million. This collaboration focuses on driving research, improving treatments, and enhancing survival rates for both children and adults.
Be Part of Research: Making a Difference
Be Part of Research, a free service that connects people with vital health and care research across the UK, has already helped over 100,000 individuals participate in 160 studies, including cancer research. By integrating Be Part of Research into the NHS App, patients with rare cancers will have even greater opportunities to find and join clinical trials that could save their lives and the lives of others.
The Impact of Clinical Trials
Science Minister, Lord Vallance, emphasizes the importance of clinical trials in turning promising research into life-saving treatments. This work, alongside efforts to speed up clinical trials in the UK, will make a significant difference in helping more cancer patients access trials and accelerating the development of life-changing treatments.
Empowering Patients with Rare Cancers
Professor Peter Johnson, National Clinical Director for Cancer at NHS England, highlights the need for rare cancer patients to be aware of their options, especially when it comes to experimental treatments for hard-to-treat cancers or those that haven't responded to previous treatments. By making it easier for people to participate in clinical trials, thousands more will have access to targeted treatments, driving vital research forward.
Improving Outcomes for Rare Cancers
Prof Lucy Chappell, DHSC Chief Scientific Advisor and Chief Executive of the NIHR, emphasizes the NIHR's mission to improve the lives of patients and their families through world-class research. With significant funding and the establishment of the Brain Tumour Research Consortium, the UK aims to ensure that people living with brain and other rare cancers are at the forefront of medical breakthroughs.
A Real-Life Success Story
More than 10,000 people are diagnosed with a brain tumour each year, yet survival rates have lagged behind other cancers. However, there are success stories like Mike Shurmer, a dad-of-three from Swindon, who, after being diagnosed with a brain tumour and given a year to live, participated in the NIHR-funded FUTURE-GB trial. This trial utilized state-of-the-art technology to remove more of the tumour without damaging brain function. Mike and his family have been given more time together, and he is now managing his condition with ongoing drug treatment and a portable, wearable medical device called Optune Gio, which targets cancer cells with low-intensity electric fields.
Breaking Down Barriers
This government is determined to tackle the barriers that prevent people from accessing the treatment they need. Participation in trials should be based on patient need, not restricted by geography or timing.
A Step-Change for Brain Cancer Patients
The Rare Cancers Bill, the Cancer Clinical Trials Accelerator, strengthened partnerships with Cancer Research UK, record funding, and the forthcoming National Cancer Plan represent a significant step forward for brain cancer patients. This initiative replaces delay and fragmentation with access, coordination, and hope.
A Consortium for Brain Cancer Research
The £32.3 million boost to brain cancer research since July 2024 includes increased investment in the NIHR Brain Tumour Research Consortium, expected to reach £25.5 million. This consortium brings together 48 organizations to deliver a nationally coordinated program of research, accelerating the development and evaluation of new brain cancer treatments for adults and children.
